Skip to Content

XALKORI 20 mg granules in capsules for opening

Licence status
Authorised: 22/08/2024
Active substances
Crizotinib
Dosage Form
Granules in capsule for opening
Licence number
EU/1/12/793/005
Licence holder
Pfizer Europe MA EEIG

Licence information

ATC code
L01ED01 crizotinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/08/2024